Indemnity & Compensation Guidelines Indemnity & Compensation Guidelines PolicyStrategic Agreement 2022-2027 Health Technology Assessment (HTA) Access to Medicines Working Group (AMWG) Clinical TrialsClinical Trial Research Agreements Indemnity & Compensation Guidelines Research & Development Taskforce (RDTF) Tele-Trials Oncology Industry TaskforceAddressing the challenges of access to new cancer medications About the OIT Reports and resources Pharma Australia Inclusion Group (PAIG) Policy Submissions Regenerative Medicines Consortium Programme Form of Indemnity – Standard Form of Indemnity – HREC Review only Compensation Guidelines
